RxDoctor Payments Data

Adam Levy, MD

Otolaryngology · Chicago, ILNPI 1366625295

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,249 of the $1,575 with a category attached, or 79.3%. 18 manufacturers reported payments, led by Acclarent, Inc at 26.4% of the total.

$1,575in general payments, 2019–2025

Across 43 payments — averaging $36.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$415
  • Integra Lifesciences Corporation$362
  • Stryker$168
  • Neurent Medical Limited$160
  • GSK$116
  • Smith+Nephew$76
  • plus $279 from 12 others
$7,802in research payments, 2019–2025

Across 4 payments — averaging $1950.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otonomy, Inc.$8K

What the payments were for

  • Food & beverage$1,24979%
  • Other$32621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,575 in reported general payments places this provider in the 55th percentile of 390 otolaryngology providers in Illinois.

See all otolaryngology providers in Illinois

Medicare billing

Part B allowed, 2024
$245,750
Medicare patients
590
Services billed
3,165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl345$8,536
Fluocinolone Acetonide Oil75$3,986
Fluticasone Propionate254$2,893
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth26$2,736
Ipratropium Bromide69$1,303
Omeprazole103$948
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort12$531
Methylprednisolone66$427
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$149

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →